Indian pharmaceutical companies Biophore and its subsidiary Zenara Pharma in Hyderabad get approval from the CDSCO for manufacturing and marketing of neuro disorder drug.
Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation (CDSCO) for manufacturing and marketing of Cannabidiol active ingredient in India.Its subsidiary, .
Hyderabad: Hyderabad-based Biophore India Pharmaceuticals has announced that it has received approval from he Central Drugs Standard Control Organisation
Hyderabad-based Biophore India Pharmaceuticals announced on Friday that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases of Covid-19.Biophore has .